chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had the shingles vaccine and still got them/ suspected vaccination failure; I had the shingles vaccine and still got them; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but selected as adult as per the vaccine indication. The patient received Shingles vaccine and still got the shingles. This case was considered as suspected vaccination failure as details regarding the completion of primary vaccination schedule, laboratory test confiding shingles and time to onset for shingles were unknown at the time of reporting.
Fever 102 degrees F, WBC 27.7.  Admitted to r/o sepsis-blood cultures neg, urine cultures neg.  5/2/08 Reviewed hospital medical records of 1/4-1/6/2008. FINAL DX: viral illness, fever of unknown origin. Records reveal patient experienced cough/stuffy nose x 2 days & fever x 1 day.  Seen in ER on 1/3/08 & admitted to r/o bacteremia.  Temp 102.8 in ER.  Tx w/IM antibiotics. Improved & d/c to home.   Patient returned to ER on 1/14/2008 w/fever & cough x 1 day.  Tx w/oral hydration & antipyretic.  D/C to home. FINAL DX: viral URI.
Client frightful prior to injection. Sat down for vaccination, followed immediately by syncope episode - did not fall, did not hit head on any object. Placed head between legs, applied cool damp cloths to face and neck. Placed flat on her back with feet elevated. Client appeared to be weak. Sat up with assistance, not able to stand. Called 911, EMS transported client to ER. Called father after event. Father said ER told him she had anxiety attack. No further problems.
mom states pt has bumps all over & itching;mom states no difficulty breathing per RN;advised mom to give DPH & go to ER immed;mom replied no DPH & will go to ER;445PM mom states pt is fine; hives dec;
Instead of giving patient 2nd dose Pfizer primary series gave her Pfizer Bivalent booster
local redness; local swelling; This case was reported by a physician via call center representative and described the occurrence of localized erythema in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced localized erythema and local swelling. On an unknown date, the outcome of the localized erythema and local swelling were recovered/resolved.   It was unknown if the reporter considered the localized erythema and local swelling to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced local redness and swelling that lasted for 24 hours. Reporter consented to follow up. This case is link with case US2020024284, reported by same reporter.
Full cardiac arrest 24 hours after receiving the second dose. Felt mildly achy and tired during the day following the second vaccine. Was walking and collapsed due to cardiac arrest.  Received prompt medical attention (CPR and three AED shocks) administered by close-by medical and emergency professionals. Stabilized and transported to ER/Cardiac Catheterization Lab where two coronary artery blockages (90+ %) were cleared and two stints inserted. Within a week after receiving my first COVID vaccine (3/30/2021), I experienced my first cardiac symptom (brief mild chest constriction) after a brisk walk. Over the next two weeks, I had a couple more incidents which were progressively longer lasting and more intense.  I visited my GP doctor to get checked out on 4/20/2021. The doctor's exam detected no cardiac issues and an EKG was run and came back normal.  I had no underlying health conditions or cardiac risk factors.
Congestive heart failure; short of breath; Myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FAILURE CONGESTIVE (Congestive heart failure), DYSPNOEA (short of breath) and MYOCARDITIS (Myocarditis) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC FAILURE CONGESTIVE (Congestive heart failure) (seriousness criteria death and medically significant), DYSPNOEA (short of breath) (seriousness criterion death) and MYOCARDITIS (Myocarditis) (seriousness criteria death and medically significant). The patient died on 28-Aug-2021. The cause of death was not reported. It is unknown if an autopsy was performed.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Brain natriuretic peptide: elevated (High) BNP is elevated. On an unknown date, Fibrin D dimer: elevated (High) D-dimer  elevated. On an unknown date, Hepatic enzyme: elevated (High) liver enzymes elevated.         No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.  Company Comment: This case concerns a consumer of unknown gender and age with no relevant medical history who experienced serious fatal unexpected events of cardiac congestive failure dyspnea, and myocarditis after receiving a second dose of the Moderna Covid 19 vaccine. Autopsy was not performed. Rechallenge is not applicable. The benefit-risk relationship is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This case concerns a consumer of unknown gender and age with no relevant medical history who experienced serious fatal unexpected events of cardiac congestive failure dyspnea, and myocarditis after receiving a second dose of the Moderna Covid 19 vaccine. Autopsy was not performed. Rechallenge is not applicable. The benefit-risk relationship is not affected by this report.; Reported Cause(s) of Death: Unknown cause of death
pt recvd vax;devel 10 spots 7 days p/ vax;f/u:26sep95 devel chicken pox;
Immediately following vaccine I experienced facial numbness on my right side of face.  There is alit of pain too..  contact doctor immediately
Rash, urticaria, Pruritis persists 2 weeks post changing locations,
After receiving vaccine daughter c/o pain to injection site for days.  c/o headache, dizziness, "stomache ache", fatigue and general malaise.  Intermittent numbness to hand/ wrist, joint and bone pain.  On August 18, patient woke with swelling to finger, collapsed 15 minutes later with syncopal episode and vomiting with "seizure like activity".  Pt transported to ER. Patient developed swelling to hands and feet with scattered rash.  Discharged with prednisone and Benadryl.  Continued to c/o joint pain and fatigue with dizziness.  August 24, while in school, severe dizziness, tremors with "seizure like activity", memory loss.  Transient numbness to extremities.  Transported to another ER and currently awaiting EEG and neurology appointment.  9/9/09 PCP medical records received DOS 8/25/08 to 8/31/09. Assessment: Medication Rxn to vaccine.  Syncope. Presented at ER with edema, SOB, syncope, slow speech, confused. Ref to neurologist. 10/23/09:  EEG Report received for date of service 9/15/09.  Assessment:  Normal awake and asleep EEG for a 15 year-old 10/23/09:  EEG Report received for date of service 9/15/09.  Assessment:  Normal awake and asleep EEG for a 15 year-old. 10/26/09 Medical records received for date 9/21/09 Neurology consultation. Presented with c/o acute encephalopathic episodes x2 one month ago and episodes of hand, foot swelling with shoot neuropathic pains in her legs and arms. Confusion, lightheadedness, syncope, joint pains, back pain, numbness in toes/hands. Pt had gardasil one month prior to episodes. Assessment: WNL except bilateral atrophy of intrinsic hand muscles.DX: no evidence of seizure will order labs.
SORE ARM; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers The outcome of sore arm was not reported. This report was non-serious.
Fever, chills, body aches, and arm soreness lasting a little over eighteen hours. Symptoms subsided with Tylenol within twenty four hours.
pt recv 3rd dose of vax & exp a syncopal episode;pt was seen in ER where the event was considered to have resolved;MD did not feel that this event was r/t vax;
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No relevant medical history of the patient was reported. Approximately in July 2014, reproted as six months ago, the patient was vaccinated with ZOSTAVAX dose 1, 0.65 ml once, subcutaneous (lot number and expiry dates were not reported) (the patient received the second dose mix months after the first dose). No concomitant medications were reported. There were no adverse effect reported. There was no product quality complaint (PQC) reported. The outcome was unknown. Additional information has been requested.
improperly stored vaccine administration; This spontaneous report refers to a currently 4-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On unknown date, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rha) (PROQUAD) dose 0.5 ml,  lot# S031703, expiry date: 06-APR-2021, for prophylaxis (dose number, route of administration were not provided).  Administered dose of vaccine experienced the temperature excursion of -9.5 degrees Celsius for 8 hours and 53 minutes and -10.1 degrees Celsius for 6 hours and 40 minutes. There were no previous excursions related. Data logger was involved.
SUBJECTIVE: Patient is a 32 Y female presenting for first visit with provider after transfer of care from Dr. to me with concerns of reaction to flu vaccine. States she received flu vaccine at 1:30pm yesterday at a pharmacy and then she developed symptoms at 10:00pm before bed that involved coughing and dyspnea and chest tightness and wheezing, hives on chest.  Took some benadryl and was able to lie down and then felt hot and chilled.  NO temp taken but she felt sweaty. Today she feels fatigued and achey.  Denies a history of asthma but gets allergies.  No recent URI or allergy symptoms the past few days, gets allergies in the spring and summer. No prior adverse events reported.  No history of egg allergy.  Pt had no symptoms today and appears well so no treatment was given.   Attempted to contact the vaccine administrator and was transferred to voice mail where a message was left indicating pt's name and reaction and my intent to file VAERS report.  I do not have any of the information on what brand or lot number was given.
Student nurse reported to RN that patient was given half the dose because some squirted out of syringe. Patient then was revaccinated with an 0.5 mL dose in opposite deltoid.
I had COVID; The first Pfizer vaccine we got it on Monday and I came down with COVID on Sunday; We were tested and we had COVID; I had COVID; The first Pfizer vaccine we got it on Monday and I came down with COVID on Sunday; We were tested and we had COVID; We were pretty sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Aug2021 (Lot number: FC3183, Expiration Date: Oct2021) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "I had COVID; The first Pfizer vaccine we got it on Monday and I came down with COVID on Sunday; We were tested and we had COVID"; ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "We were pretty sick". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (2021) positive. Therapeutic measures were not taken as a result of covid-19, illness. Clinical course: This is the first case out of two cases in which reporter is calling for herself (Consumer). She does not know what they put in the vaccines, but the first one she had was okay. When confirmed that the consumer got COVID after receiving Pfizer COVID 19 Vaccine, Consumer stated, "Yes, the first Pfizer vaccine we got it on Monday and on Saturday her husband came down with COVID and she did on Sunday and they were pretty sick. They were tested and they had COVID. Then they did monoclonal antibody, so they had to wait for 3 months and then they decided okay they will have the second Pfizer. Her husband reacted better, but she had all of this, she was feeling better now but out of the 21 side effects she had 10 and one that she just told us, she almost fell on the ground, 11. So half of the side effects she had. The patient inquired about booster and said that what are they putting in this vaccine (General statement)." Consumer was informed about the role of Pfizer Drug Safety and requested to probe. The consumer did not had any vaccination 4 weeks prior to COVID 19 Vaccine.   No follow-up attempts are possible. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of severe swelling at injection site in a 39-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). Previous and/or concurrent vaccination included pneumonia vaccine (non-gsk); Merck; unknown given on 12 October 2010. Concurrent medications included COREG, Lisinopril, NIASPAN, PLAVIX and Metoprolol. On 12 October 2010 at 15:00 the subject received 1st dose of FLULAVAL (0.5 ml, unknown, right arm). On 12 October 2010, immediately after vaccination with FLULAVAL, the subject experienced severe swelling injection site, redness and injection site hot to touch. Three to four hours after receiving FLULAVAL, the subject developed a high fever that ranged from 101 to 104 degrees Fahrenheit and right sided lymph node swelling. The subject required medical attention at the doctor's office. There was follow-up with the subject on 13 October 2010 and he was prescribed AUGMENTIN and told to take TYLENOL every four hours with fluids and rest. It was reported that the adverse events were local and systemic. At the time of reporting the severe swelling swelling at injection site, hot to touch at injection site, fever, and right sided lymph node swelling were unresolved. The outcome of the injection site redness was unspecified. The healthcare professional considered the severe swelling at injection site, hot to touch at injection site, fever of 101-103, and right sided lymph node swelling were probably related to vaccination with FLULAVAL.
Vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) in a 40-week-old male infant exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) , while the mother received the product for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The mother's past medical history included Maternal exposure during breast feeding.    No Medical History information was reported.    On 24-Mar-2021, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The mother's last menstrual period was on 19-Aug-2020 and the estimated date of delivery. On an unknown date, the infant was diagnosed with EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk). The Infant was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The vaginal delivery occurred  which was reported as Full-term. For neonate 1, the birth weight was 3500 grams (7lbs 11oz). The outcome was reported as Delivered NOS. Complication during pregnancy: Yes. At the time of the report, EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) outcome was unknown.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Transmammary), the reporter did not provide any causality assessments. Date of positive pregnancy test: 23-SEP-2020. Mother had test on 3-MAR and Glucose intolerance test on 17-MAR-2021 as normal.  Mother has history of prior alcohol consumption. Mother took prenatal vitamin and vitamin-D during pregnancy.  No treatment medication was reported by reporter.  Upon internal review on 03-Nov-2021, In the Patient tab child only case and  Patient route of administration to Transmammary is updated.   This case was linked to MOD-2021-058260 (Parent-Child Link).   See case MOD-2021-058260 for details regarding the Parent case.
I WAS OK THAT DAY JUST A BIT TIRED ANS WENY TO WORK. I WOKE UP THE NEXT DAY WITH CHILLS AND I STARTED WITH A HEADACH AND THE SECOND DAY I WOKE UP WITH BACK PAIN AND ENT TO THE ER BUT WAS NOT ADMITTED. THEY GAVE ME A TORADOL INJECTION AND DID A URIN TEST. THEN SENT ME HOME WITH INSTRUCTIONS TO TAKE IBPROPHEN.   SEEN DR. ON JULY 26 FOR THE DAME THING AND SHE DID PROSCRIBE A MUSCLE RELAXER AND ONCE A DAY ANTI-INFLAMATORY MYLOXICAM.   METHOCARBAMOL 500 GM.   2ND ER ON 7/27/2022 TO ER FOR ANOTHER 8 HOURS THEY DID ANOTHER URINE TEST, XRAY OF BACK HIP AND CT WITH CONTRAST AND NOTHING FOUND. SENT HOME AFTER THAT.  ABOUT TO WEEKS TO THE DAY MY BACK STOPED HURTING. YESTERDAY I STARTED FILLING LIKE MY TONSILS WERE IN THE WAY SO I WENT TO THE URGENT CARE AT WALKIN. THEY SAID EVERYTHIN LOOKED GOOD WITH NO INFECTION BUT IT LOOKED LIKE MUCOUS AND POST NASIL DRIP.
mild itching on the left side of the body 10 minutes after receiving the injection. The itching disappeared after about three hours.; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN6199) via an unspecified route of administration in left arm on 06Mar2021 13:45 (at 42 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. There was no relevant medical history. The patient had no known allergies. Concomitant medications included atorvastatin 20 mg and fluoxetine 40mg, both daily for unspecified date for unspecified indication. The patient did not have COVID prior to vaccination and was not tested for COVID post vaccination. The patient experienced mild itching on the left side of the body 10 minutes after receiving the injection. The itching disappeared after about 3 hours. The event was non-serious on 06Mar2021 at 14:00. No treatment was given due to the event. Outcome of the event was recovered on 06Mar2021.   No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a patient who was allergic to PNEUMOVAX 23. It was unknown if medical attention was sought. The outcome of the patient was not reported. No further information is available.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:01/12/21pfizer,Lot#EL3248 2nd dose:02/02/21,Pfizer,Lot# EN5318 Diagnosed covid positive:04/13/21 Exposure:Home Symptoms:Runny nose,HA
Vet came into clinic stating she wanted to be vaccinated. After writer administered vaccine, she stated she had the pfizer previously and it gave her a rash on her arm. Writer did not know she had received pfizer dose until after moderna dose was given. Vet reports headache today
Patient is a 47-year-old female who reported no problems with her first 3 anthrax (AVA) immunizations. On 28 June 04 she received AVA # 4. At that time she reported an initial lump that resolved after 3 wks. She had no further soreness. Then around the beginning of August she noticed some soreness and "mosquito bite" like lesions around the injection site. She also stated that the lump, approx size of a pea, had returned. She stated that the lesions lasted 2 days, and then followed by a period of itching for 2-3 days and then 7-10 days later she started to notice the bumps again that lasted 2-3 days before it cleared. She also reported itching again following clearing of the lesions. She stated that even though the lesions would clear, her arm would always feel sore in the area. She described the lesions as raised little bumps, no fluid filled, soft, and usually 3 separate bumps. She would notice slight itching but nothing like the itching that followed the clearing. No lesions on any other parts of her body. She stated that she never had lesions like this before. Patient denied any other problems but during a review of systems additional areas of concern were noted. She began to notice that the joints in her hand had increased in size. She was told that she had osteoarthritis of her hands and that she first noticed symptoms in Dec/Jan last year. She stated that only her left hand is involved and that she is left handed. She stated that she has pain in the mornings and that the pain increases with use during the day. Did not notice any change in the pain in relation to her anthrax immunizations. She also has left knee pain but stated that this was due to a fall that she sustained while in Iraq. She also reported left shoulder pain. She began to notice this around mid August. She has decrease range of motion and has a possible rotator cuff injury. She reports that a physical therapy consult is pending. She does not recall an injury and initially though it was from sleeping wrong. During the week of 06 Sep 04 she developed an episode of chest pain that woke her up from her sleep. She stated that it was a sharp pain that lasted 20 minutes and that she did experience shortness of breath. She denied diaphoresis and stated that nothing made the pain better or worse. Pain was # 6 on scale of 1-10 with 10 being worse. Did have one other episode since the first that was similar to the first episode and again occurred at night. She thought it was gas. She stated that her colonoscopy in Aug found 3 polyps and her endoscopy revealed esophagitis and reflux. Symptom: Nodule, epidermal Start: 06/28/2004 Comment: resolving in three weeks Symptom: Lesions, Vesicle Start: 08/01/2004 Symptom: Pain start: 08/01/2004 Comment: soreness Symptom: Pruritus Start: 08/01/2004